Internal medicine

Geology

Pathology

Placebo

Oceanography

Baseline (sea)

Asthma

Exacerbation

Alternative medicine

Lung

Dupilumab

Lung function

Medicine

European Respiratory Journal

<b>Dupilumab treatment <i>versus</i> placebo improved exacerbation rate and lung function outcomes in patients with uncontrolled moderate-to-severe asthma and high type 2 biomarkers at baseline, regardless of baseline characteristics in the phase 3 QUEST study</b>https://bit.ly/3yR7MlD

Impact of baseline patient characteristics on dupilumab efficacy in type 2 asthma